A medically formulated THC and CBD treatment reduced agitation in a blinded trial involving people with late-stage dementia. Restlessness, aggression, and emotional distress can make late-stage dementia especially difficult for patients and caregivers. In a first-of-its-kind U.S. clinical trial, a specially prepared medication containing tetrahydrocannabinol (THC) and cannabidiol (CBD), two active compounds in marijuana, significantly [...]from SciTechDaily https://ift.tt/pBEgPZQ
